Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout

Yam, Jason C., Zhang, Xiu Juan, Zhang, Yuzhou, Wang, Yu Meng, Tang, Shu Min, Li, Fen Fen, Kam, Ka Wai, Ko, Simon T., Yip, Benjamin H.K., Young, Alvin L., Tham, Clement C., Chen, Li Jia, Pang, Chi Pui · 2022 · Ophthalmology

Abstract

PURPOSE (1) To compare the efficacy of continued and stopping treatment for 0.05%, 0.025% and 0.01% atropine during the third year. (2) To evaluate the efficacy of continued treatment over 3 years. (3) To investigate the rebound phenomenon and its determinants after cessation of treatment. DESIGN A randomized, double-masked extended trial PARTICIPANTS: 350 of 438 children aged 4-12 years originally recruited into the Low-Concentration Atropine for Myopia Progression (LAMP) study METHODS: At the beginning of the third year, children in each group were randomized at a 1:1 ratio to a continued treatment and washout subgroup. Cycloplegic spherical equivalent (SE) refraction and axial length (AL) were measured at 4-month intervals. MAIN OUTCOMES MEASURES Changes in SE and AL between groups RESULTS: 326 children completed 3 years of follow-up. During the third year, SE progression and AL elongation were faster in the washout subgroups than in the continued treatment groups across all concentrations (-0.68±0.49D vs.-0.28±0.42D (P<0.001) and 0.33±0.17mm vs. 0.17±0.14mm (P<0.001) for the 0.05%; -0.57±0.38D vs. -0.35±0.37D (P=0.004) and 0.29±0.14mm vs. 0.20±0.15mm (P=0.04) for the 0.025%; -0.56±0.40D vs.-0.38±0.49D (P=0.04) and 0.29±0.15mm vs 0.24±0.18mm (P=0.13) for the 0.01%). Over the 3-year period, SE progressions were -0.73±1.04D, -1.31±0.92D, and -1.60±1.32D (P=0.001) for the 0.05%, 0.025%, and 0.01% groups in the continued treatment subgroups, -1.15±1.13D, -1.47±0.77D, and -1.81±1.10D (P=0.03) in the washout subgroup. The respective AL elongation were 0.50±0.40mm, 0.74±0.41mm, and 0.89±0.53mm(P<0.001) for the continued treatment subgroups, and 0.70±0.47mm, 0.82±0.37 mm, and 0.98±0.48mm(P=0.04) for the washout subgroup. The rebound SE progressions during washout were concentration dependent but their differences were clinically small (P=0.15). Older age and lower concentration were associated with smaller rebound effects in both SE progression (P<0.001) and AL elongation (P<0.001). CONCLUSIONS During the third year, continued atropine treatment achieved a better effect across all concentrations compared to the washout regimen. 0.05% atropine remained the optimal concentration over 3 years in Chinese children. The difference in rebound effects were clinically small across all three studied atropine concentrations. Stopping treatment at an older age and lower concentration is associated with a smaller rebound.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2021.10.002

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Metadata

Authors
Yam, J. C., Zhang, X. J., Zhang, Y., Wang, Y. M., Tang, S. M., Li, F. F., Kam, K. W., Ko, S. T., Yip, B. H. K., Young, A. L., Tham, C. C., Chen, L. J., & Pang, C. P.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2022-03
Volume
129
Issue
3
Pages
308-321
ISSN
0161-6420 (ISSN-L)
OpenAlex
W3206179811
Cited by
222
References
3
FWCI
18.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. https://app.cochat.ai/papers/10.1016/j.ophtha.2021.10.002
The paper
Yam, J. C., Zhang, X. J., Zhang, Y., Wang, Y. M., Tang, S. M., Li, F. F., Kam, K. W., Ko, S. T., Yip, B. H. K., Young, A. L., Tham, C. C., Chen, L. J., & Pang, C. P. (2022). Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. Ophthalmology. https://doi.org/10.1016/j.ophtha.2021.10.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.